JP4762472B2 - 血液学的アッセイ及び試薬 - Google Patents

血液学的アッセイ及び試薬 Download PDF

Info

Publication number
JP4762472B2
JP4762472B2 JP2001545856A JP2001545856A JP4762472B2 JP 4762472 B2 JP4762472 B2 JP 4762472B2 JP 2001545856 A JP2001545856 A JP 2001545856A JP 2001545856 A JP2001545856 A JP 2001545856A JP 4762472 B2 JP4762472 B2 JP 4762472B2
Authority
JP
Japan
Prior art keywords
factor
sample
clotting
assay
coagulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2001545856A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003517610A (ja
JP2003517610A5 (enExample
Inventor
ゲンペラー，パトリツィア・マリア
カラツィス，アンドレアス
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DSM IP Assets BV
Original Assignee
DSM IP Assets BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DSM IP Assets BV filed Critical DSM IP Assets BV
Publication of JP2003517610A publication Critical patent/JP2003517610A/ja
Publication of JP2003517610A5 publication Critical patent/JP2003517610A5/ja
Application granted granted Critical
Publication of JP4762472B2 publication Critical patent/JP4762472B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/4609—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates from reptiles
    • G01N2333/4613—Snake venom
    • G01N2333/4616—Snake venom from Russell's viper
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G01N2333/7456—Factor V
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)
    • G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
    • G01N2333/96444—Factor X (3.4.21.6)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2001545856A 1999-12-15 2000-12-14 血液学的アッセイ及び試薬 Expired - Lifetime JP4762472B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP99/09952 1999-12-15
PCT/EP1999/009952 WO2001044493A2 (en) 1999-12-15 1999-12-15 Hematological assay and reagent
EPPCT/EP99/09952 1999-12-15
PCT/EP2000/012753 WO2001044819A2 (en) 1999-12-15 2000-12-14 Hematological assay and reagent

Publications (3)

Publication Number Publication Date
JP2003517610A JP2003517610A (ja) 2003-05-27
JP2003517610A5 JP2003517610A5 (enExample) 2007-12-27
JP4762472B2 true JP4762472B2 (ja) 2011-08-31

Family

ID=8167528

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001545856A Expired - Lifetime JP4762472B2 (ja) 1999-12-15 2000-12-14 血液学的アッセイ及び試薬

Country Status (9)

Country Link
US (1) US6994984B2 (enExample)
EP (1) EP1240528B1 (enExample)
JP (1) JP4762472B2 (enExample)
AT (1) ATE312352T1 (enExample)
AU (2) AU2431800A (enExample)
CA (1) CA2392350C (enExample)
DE (1) DE60024669T2 (enExample)
ES (1) ES2254260T3 (enExample)
WO (2) WO2001044493A2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022145477A1 (ja) * 2020-12-28 2022-07-07 藤森工業株式会社 血液凝固検査方法

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6680177B2 (en) * 2001-12-07 2004-01-20 Cardiovascular Diagnostics, Inc. Low molecular weight heparin assay, system and reagent therefor
US7358337B2 (en) * 2002-08-16 2008-04-15 International Technidyne Corporation Assay for low molecular weight heparin
ES2390271T3 (es) * 2003-09-22 2012-11-08 University Of North Carolina At Chapel Hill Fosfolípidos solubles para uso en ensayos de factores de coagulación
AU2005243161A1 (en) * 2004-05-11 2005-11-24 Heptest Laboratories, Inc. Compositions, kit and one-step method for monitoring compounds having anti-factor Xa and/or anti factor iia activities
GB2433592A (en) * 2005-12-23 2007-06-27 Pentapharm Ag Assay for thrombin inhibitors
EP1918718A1 (de) * 2006-10-31 2008-05-07 Roche Diagnostics GmbH Verfahren und Vorrichtungen zur elektrochemischen Bestimmung von Faktor Xa-Inhibitoren in Blutproben
EP2333555A1 (de) 2009-12-09 2011-06-15 Siemens Healthcare Diagnostics Products GmbH Heterogener Gerinnungstest
JP2011133396A (ja) * 2009-12-25 2011-07-07 Sysmex Corp 活性化部分トロンボプラスチン時間測定試薬、活性化部分トロンボプラスチン時間測定方法、及び血液凝固抑制物質の有無の判定方法
EP2484775A1 (de) * 2011-02-07 2012-08-08 Siemens Healthcare Diagnostics Products GmbH Heparin-insensitives Verfahren zur Bestimmung von direkten Gerinnungsfaktorinhibitoren
RU2517116C2 (ru) * 2012-07-03 2014-05-27 Государственное бюджетное учреждение Санкт-Петербургский научно-исследовательский институт скорой помощи им. И.И. Джанелидзе Способ оценки состояния свертывающей системы крови у пациентов, находящихся в критическом состоянии
EP3970738A1 (en) 2012-07-25 2022-03-23 Bioverativ Therapeutics Inc. Blood factor monitoring assay and uses thereof
US9651567B2 (en) 2013-05-14 2017-05-16 Cgt Enterprises, Llc Test strips for determining coagulation factor activities
US20160305966A1 (en) 2013-12-09 2016-10-20 Dsm Ip Assets B.V. Identification of anticoagulants in a sample
US10786553B2 (en) 2014-10-23 2020-09-29 Q-Sera Pty Ltd. Clotting composition
JP6873833B2 (ja) * 2017-06-09 2021-05-19 シスメックス株式会社 血液検体の判定方法、血液検体分析装置及びコンピュータプログラム
CA3078625C (en) 2017-10-09 2023-01-17 Terumo Bct Biotechnologies, Llc Lyophilization container and method of using same
CN109082458B (zh) * 2018-08-16 2024-02-23 上海原科实业发展有限公司 一种血栓弹力图法定量检测口服凝血因子Xa抑制剂试剂盒及其制备方法
CN108982865B (zh) * 2018-08-16 2021-05-11 上海原科实业发展有限公司 一种血栓弹力图法肝素定量检测试剂盒及其制备方法
CN109709344A (zh) * 2018-12-29 2019-05-03 贵州金玖生物技术有限公司 一种活化凝血检测试剂、其制备方法及其应用
CA3224729A1 (en) 2019-03-14 2020-09-17 Terumo Bct Biotechnologies, Llc Lyophilization loading tray assembly and system
CN110244066A (zh) * 2019-07-01 2019-09-17 北京乐普医疗科技有限责任公司 一种干式电化学法凝血酶原时间检测卡及制备方法
CN110887970B (zh) * 2019-11-29 2023-10-31 北京赛科希德科技股份有限公司 抽提缓冲液、兔脑抽提液、pt检测试剂及pt检测试剂盒
AU2021260947A1 (en) * 2020-04-24 2022-12-01 Perosphere Technologies Inc. Whole blood control sample systems and method of preparing and using the same
EP4270010A4 (en) * 2020-12-28 2024-11-20 Fujimori Kogyo Co., Ltd. METHOD FOR EVALUATING BLOOD COAGULATION PERFORMANCE, AND METHOD FOR INSPECTING THROMBOSIS RISK
JP2024514307A (ja) 2021-03-31 2024-04-01 ヘモネティクス・コーポレーション 血液凝固測定装置の品質管理配合物
CN114703252B (zh) * 2022-06-02 2022-11-04 深圳市帝迈生物技术有限公司 一种用于检测血浆中水蛭素、比伐卢定、达比加群含量的试剂盒
WO2024163247A1 (en) * 2023-02-01 2024-08-08 Haemonetics Corporation Disposable cartridge for classification of anticoagulant and method of use

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3516579A1 (de) 1984-11-19 1986-05-22 Boehringer Mannheim Gmbh, 6800 Mannheim Gerinnungstest auf teststreifen
US4756884A (en) 1985-08-05 1988-07-12 Biotrack, Inc. Capillary flow device
US5164598A (en) 1985-08-05 1992-11-17 Biotrack Capillary flow device
US4946775A (en) 1985-09-05 1990-08-07 Yin E Thye Composition, kit and method for assaying heparin and a method for making the composition
DE3616496A1 (de) 1986-05-16 1987-11-19 Boehringer Mannheim Gmbh Analyseelement zur bestimmung von gerinnungsparametern
US5110727A (en) 1987-04-03 1992-05-05 Cardiovascular Diagnostics, Inc. Method for performing coagulation assays accurately, rapidly and simply, using dry chemical reagents and paramagnetic particles
US5266462A (en) * 1992-06-03 1993-11-30 Baxter Diagnostics Inc. Measurement of platelet activities
WO1999002992A1 (en) * 1997-07-11 1999-01-21 The Mount Sinai School Of Medicine Of The City University Of New York Assays for diagnosis of thrombophilic disease

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022145477A1 (ja) * 2020-12-28 2022-07-07 藤森工業株式会社 血液凝固検査方法

Also Published As

Publication number Publication date
EP1240528A2 (en) 2002-09-18
US20030104508A1 (en) 2003-06-05
CA2392350C (en) 2010-11-02
CA2392350A1 (en) 2001-06-21
DE60024669T2 (de) 2006-09-28
ES2254260T3 (es) 2006-06-16
WO2001044819A3 (en) 2001-12-06
AU3159301A (en) 2001-06-25
DE60024669D1 (de) 2006-01-12
AU2431800A (en) 2001-06-25
EP1240528B1 (en) 2005-12-07
WO2001044493A2 (en) 2001-06-21
JP2003517610A (ja) 2003-05-27
US6994984B2 (en) 2006-02-07
AU776845B2 (en) 2004-09-23
ATE312352T1 (de) 2005-12-15
WO2001044819A2 (en) 2001-06-21

Similar Documents

Publication Publication Date Title
JP4762472B2 (ja) 血液学的アッセイ及び試薬
EP0420332B1 (en) Method for determining the endogenous thrombin potential of plasma and blood, and also a kit for use in said method
US5051357A (en) Method and assay using inactivation of factors Va and VIIIa by activated Protein C to diagnose thrombic disease or assay for Protein C and kit therefor
JP4361980B2 (ja) サンプルの潜在的抗血液凝固能の測定法
Bergström et al. Determination of vitamin K sensitive coagulation factors in plasma. Studies on three methods using synthetic chromogenic substrates
US5525478A (en) Soluble thrombomodulin-based one-stage assay for vitamin-K dependent coagulation-inhibiting proteins
JPH11225796A5 (enExample)
EP0830608B1 (en) Thrombosis risk test
JPH08220091A (ja) 活性化状態の活性化タンパク質ｃに対する安定性が増大された凝固ｖ因子を特異的に検出する方法
Walenga et al. Newer avenues in the monitoring of antithrombotic therapy: The role of automation
US7727736B2 (en) Soluble phospholipids for use in clotting factor assays
Francis Jr A simplified PTT-based protein C activity assay using the thrombin-thrombomodulin complex
US20090221012A1 (en) Method for Detecting Procoagulant Phospholipid
WO2007072197A1 (en) Methods and systems for detecting and quantifying indirect thrombin inhibitors
AU729843B2 (en) Method for the functional detection of disorders in the protein C system
JPH04350560A (ja) プロテインｓ活性の機能的測定方法
Fernández et al. Activated protein C correlates inversely with thrombin levels in resting healthy individuals
US5200322A (en) Method for assaying protein C and measuring kit for the same
WO2025132678A1 (en) Qualitative test for direct oral anticoagulants (doacs)
AU2004274516B2 (en) Method for detecting procoagulant phospholipid
Kirchhof et al. Determination of prothrombin by a micro-coagulation method
Esmon The role of protein C and thrombomodulin in the regulation of blood coagulation
MXPA00012813A (en) Methods for performing fibrinogen assays using dry chemical reagents containing ecarin and magnetic particles

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20071025

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20071025

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20071025

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20081009

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100209

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100507

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100514

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100608

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100615

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100708

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100715

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100806

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20101221

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110317

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110325

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110420

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20110517

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20110608

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140617

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Ref document number: 4762472

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: R3D02

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term